TY - JOUR
T1 - A Cholesterol-Based Allostery Model of T Cell Receptor Phosphorylation
AU - Swamy, Mahima
AU - Beck-Garcia, Katharina
AU - Beck-Garcia, Esmeralda
AU - Hartl, Frederike A.
AU - Morath, Anna
AU - Yousefi, O. Sascha
AU - Dopfer, Elaine Pashupati
AU - Molnár, Eszter
AU - Schulze, Anna K.
AU - Blanco, Raquel
AU - Borroto, Aldo
AU - Martín-Blanco, Nadia
AU - Alarcon, Balbino
AU - Höfer, Thomas
AU - Minguet, Susana
AU - Schamel, Wolfgang W A
PY - 2016/5/17
Y1 - 2016/5/17
N2 - Signaling through the T cell receptor (TCR) controls adaptive immune responses. Antigen binding to TCRαβ transmits signals through the plasma membrane to induce phosphorylation of the CD3 cytoplasmic tails by incompletely understood mechanisms. Here we show that cholesterol bound to the TCRβ transmembrane region keeps the TCR in a resting, inactive conformation that cannot be phosphorylated by active kinases. Only TCRs that spontaneously detached from cholesterol could switch to the active conformation (termed primed TCRs) and then be phosphorylated. Indeed, by modulating cholesterol binding genetically or enzymatically, we could switch the TCR between the resting and primed states. The active conformation was stabilized by binding to peptide-MHC, which thus controlled TCR signaling. These data are explained by a model of reciprocal allosteric regulation of TCR phosphorylation by cholesterol and ligand binding. Our results provide both a molecular mechanism and a conceptual framework for how lipid-receptor interactions regulate signal transduction. The TCR can adopt an inactive, resting or an active, primed state. Schamel and colleagues show that the TCR is in equilibrium between these states. Peptide-MHC binding stabilizes the primed state that can be phosphorylated. Cholesterol binding stabilizes the resting state and thereby tunes the TCR activation threshold.
AB - Signaling through the T cell receptor (TCR) controls adaptive immune responses. Antigen binding to TCRαβ transmits signals through the plasma membrane to induce phosphorylation of the CD3 cytoplasmic tails by incompletely understood mechanisms. Here we show that cholesterol bound to the TCRβ transmembrane region keeps the TCR in a resting, inactive conformation that cannot be phosphorylated by active kinases. Only TCRs that spontaneously detached from cholesterol could switch to the active conformation (termed primed TCRs) and then be phosphorylated. Indeed, by modulating cholesterol binding genetically or enzymatically, we could switch the TCR between the resting and primed states. The active conformation was stabilized by binding to peptide-MHC, which thus controlled TCR signaling. These data are explained by a model of reciprocal allosteric regulation of TCR phosphorylation by cholesterol and ligand binding. Our results provide both a molecular mechanism and a conceptual framework for how lipid-receptor interactions regulate signal transduction. The TCR can adopt an inactive, resting or an active, primed state. Schamel and colleagues show that the TCR is in equilibrium between these states. Peptide-MHC binding stabilizes the primed state that can be phosphorylated. Cholesterol binding stabilizes the resting state and thereby tunes the TCR activation threshold.
UR - http://www.scopus.com/inward/record.url?scp=84967142343&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2016.04.011
DO - 10.1016/j.immuni.2016.04.011
M3 - Article
C2 - 27192576
AN - SCOPUS:84967142343
SN - 1074-7613
VL - 44
SP - 1091
EP - 1101
JO - Immunity
JF - Immunity
IS - 5
ER -